Etoposide Alternatives Compared
Etoposide | Nivolumab | Bleomycin |
|
---|
Etoposide | Nivolumab | Bleomycin |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Small Cell Lung Cancer, Hodgkin's Lymphoma, Ovarian Cancer, Cancer, Testicular Cancer, Multiple Myeloma. Etoposide may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Esophageal Carcinoma, Head and Neck Cancer, Colorectal Cancer, Hepatocellular Carcinoma, Hodgkin's Lymphoma, Malignant Pleural Mesothelioma, Melanoma, Melanoma - Metastatic, Non Small... View more |
Prescription only
Prescribed for Malignant Pleural Effusion, Testicular Cancer, Hodgkin's Lymphoma, Squamous Cell Carcinoma, Non-Hodgkin's Lymphoma. Bleomycin may also be used for purposes not listed in this medication guide. View more |
Related suggestions Hodgkin's Lymphoma
Popular comparisons
|
|||||||||||||||
More about Etoposide | More about Nivolumab | More about Bleomycin | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Nivolumab has an average rating of 5.5 out of 10 from a total of 128 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 45% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
Lower cost generic |
N/A |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Etoposide prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Bleomycin prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Etopophos, Toposar | Opdivo | Bleo 15k | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
11 hours |
640.8 hours |
30 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 447 drugs are known to interact with Etoposide:
|
A total of 402 drugs are known to interact with Nivolumab:
|
A total of 264 drugs are known to interact with Bleomycin:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
December 30, 1986 |
December 22, 2014 |
July 31, 1973 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.